Page last updated: 2024-11-12
tylopeptin b
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
tylopeptin B: isolated from Tylopilus neofelleus; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 10441590 |
| CHEMBL ID | 4213239 |
| MeSH ID | M0357020 |
Synonyms (2)
| Synonym |
|---|
| tylopeptin b |
| CHEMBL4213239 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (4)
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1378319 | Antibacterial activity against Staphylococcus aureus R-209 assessed as diameter of inhibition zone at 50 ug measured after 24 hrs by agar diffusion method | 2017 | Journal of natural products, 07-28, Volume: 80, Issue:7 | Mushroom-Derived Indole Alkaloids. |
| AID1378320 | Antibacterial activity against Corynebacterium lilium assessed as diameter of inhibition zone at 50 ug measured after 24 hrs by agar diffusion method | 2017 | Journal of natural products, 07-28, Volume: 80, Issue:7 | Mushroom-Derived Indole Alkaloids. |
| AID1378322 | Antibacterial activity against Bacillus subtilis IFO-12732 assessed as diameter of inhibition zone at 50 ug measured after 24 hrs by agar diffusion method | 2017 | Journal of natural products, 07-28, Volume: 80, Issue:7 | Mushroom-Derived Indole Alkaloids. |
| AID1378321 | Antibacterial activity against Bacillus subtilis IAM 1609 assessed as diameter of inhibition zone at 50 ug measured after 24 hrs by agar diffusion method | 2017 | Journal of natural products, 07-28, Volume: 80, Issue:7 | Mushroom-Derived Indole Alkaloids. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
Research
Studies (6)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 13.05
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (13.05) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (16.67%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (83.33%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||